Drug Type Small molecule drug |
Synonyms Lopressidone |
Action inhibitors, antagonists |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), β1-adrenergic receptor antagonists(Beta-1 adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (31 Dec 1987), |
Regulation- |
Molecular FormulaC14H11ClN2O4S |
InChIKeyJIVPVXMEBJLZRO-UHFFFAOYSA-N |
CAS Registry77-36-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | United States | 31 Dec 1987 |